Volume | 414,844 |
|
|||||
News | - | ||||||
Day High | 12.62 | Low High |
|||||
Day Low | 11.81 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Inovio Pharmaceuticals Inc New | INO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
12.62 | 11.81 | 12.62 | 12.00 | 12.79 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
7,637 | 414,844 | US$ 12.15 | US$ 5,041,960 | - | 3.888 - 14.748 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:55:24 | 25 | US$ 11.99 | USD |
Inovio Pharmaceuticals Inc New Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
280.44M | 23.37M | - | 832k | -135.12M | -5.78 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Inovio Pharmaceuticals News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.15 | 13.44 | 10.50 | 12.15 | 415,688 | 0.85 | 7.62% |
1 Month | 10.20 | 13.44 | 9.285 | 11.41 | 298,703 | 1.80 | 17.65% |
3 Months | 7.67 | 14.748 | 7.08 | 11.09 | 441,600 | 4.33 | 56.45% |
6 Months | 4.98 | 14.748 | 4.20 | 7.79 | 1,774,296 | 7.02 | 140.96% |
1 Year | 8.28 | 14.748 | 3.888 | 6.42 | 3,893,088 | 3.72 | 44.93% |
3 Years | 78.36 | 123.96 | 3.888 | 33.95 | 4,755,298 | -66.36 | -84.69% |
5 Years | 40.80 | 426.00 | 3.888 | 122.45 | 9,073,051 | -28.80 | -70.59% |
Inovio Pharmaceuticals Description
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. |